Page 2 - Thomas Eldered News Today

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move its production abroad. 34-year-old Thomas was facing an imminent risk of losing his job. However, instead, it actually turned out to be the starting point for one of the biggest success stories in Swedish life science.

NorthX Biologics appoints industry veterans to its board of directors - read this article along with other careers information, tips and advice on BioSpace

STOCKHOLM, March 29, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it has secured a private placement of SEK 132 million, to existing and new investors, led by Flerie Invest

/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it has secured a private placement of SEK 132 million, to existing and new investors, led by Flerie...

/PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted personalized...

Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics - read this article along with other careers information, tips and advice on BioSpace

STOCKHOLM, Feb. 15, 2022 /PRNewswire/ -- Eurocine Vaccines AB ("Eurocine Vaccines" or "the Company") announces today that the Company has agreed to secure warrants of series TO 4 ("TO 4") with

Synerkine Pharma Raises EUR 3.5 Million in an Extended Series A Financing - read this article along with other careers information, tips and advice on BioSpace

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Thomas Eldered as Chairman of the Board. Thomas Eldered succeeds Steve